SquamousCellCarcinomaofSkin near Elmhurst, NY

Biography: Dr. Furman is Director of the CLL Research Center at Weill Cornell Medicineand a member of the Lymphoma/Myeloma Service in the Division of Hematology/Oncology. His area of focus is on the development of non-chemotherapeutic approaches to treating CLL, and has played an integral part in the development of ibrutinib and idelalisib.For More Videos, please see below:Lymphoma Cancer Treatment NY - Weill Cornell

Biography: Dr. Henry Lee is Associate Attending Physician at New York Presbyterian Hospital and Associate Professor of Dermatology at Weill Cornell Medical College.Dr. Lee's practice focuses on medical, surgical, and cosmetic dermatology. He has a broad interest in medical dermatology but pursues a particular interest in autoimmune cutaneous disorders and collagen vascular disorders. He also maintains an active interest in aesthetic dermatology, including,lasers andBotox. Dr. Lee provides laser therapy for the treatment of broken blood vessels (telangiectasias), age/sun spots and hair removal.Dr. Henry Lee received his Bachelor of Science in Biology with a concentration in Anthropology from the Massachusetts Institute of Technology. He pursued his medical studies at Tufts University School of Medicine, where he received an MD-PhD degree. Dr. Lee's PhD research concentrated on cell cycle programming and survival pathways of quiescent lymphocytes.Dr. Lee completed his internship in Internal Medicine at the UCLA - VA Greater Los Angeles program. He completed his residency in Dermatology at New York-Presbyterian Hospital/Weill Cornell Medical Center, where he was awarded the Distinguished House Staff Award. During his residency he published papers and a book chapter on autoimmune cutaneous disorders.

Care Philosophy: Dr. Ritchie's research interests are in the treatment of older patients with anemia, cytopenias, myelodysplastic syndromes, myeloproliferative disorders and acute leukemia. She is interested in finding better therapies and supportive care strategies for older patients. Dr. Ritchie is the principal investigator on clincal trials investigating new diagnostic techniques, supportive care strategies and therapeutics aimed at the older patient. She collaborates with investigators in the Division of Geriatrics and Gerontology. She has been the author or co-author of many publications. She is interested in improving the medical care of older patients with hematologic malignancies.

Biography: Fellowship: Hematology/Oncology at New York Presbyterian Hospital, 1997-2000Residency: New York Presbyterian Hospital, 1995-97Internship: The Beth Israel Hospital, Boston 1994-95Medical School: The Mount Sinai School of Medicine, New York, 1994Undergraduate: Yale University, 1990

Care Philosophy: Our Lymphoma group has been at the forefront in the development of targeted therapies for CLL and other lymphoid malignancies. We strive to bring effective therapeutics to patients, years before they are widely available. I am fortunate to practice oncology in such an exciting era with rapidly improving diagnostic and therapeutic options. I seek to incorporate the latest breakthroughs and technology in providing care to my patients. Comprehensive in my approach, I am driven to understand the underlying biology of the disease, individualizing each patient's treatment plan. I offer patients a unique experience, with compassion for the patient and their family. With a large portfolio of clinical trials, our group offers ample opportunities for patients to participate in clinical research. Our hospital system is award winning and provides access to world-class consultants for all medical conditions. It will be a privilege to care for you or your family member.

Biography: Pinkal Desai MD, MPH is an Assistant Professor of Medicine at Weill Cornell Medical College and Assistant Attending Physician at the New York-Presbyterian Hospital.After obtaining her MBBS at Byramjeejeebhoy Medical College in India in 2005, Dr. Desai obtained an MPH at the University of Alabama at Birmingham School of Public Health. Following her residency at Wayne State University, Detroit Medical Center, she underwent fellowship training in Hematology-Medical Oncology at Providence Hospital Medical Center, serving as Chief Fellow from 2012-2013. Dr. Desai was recruited to serve in our Leukemia Program to develop a clinical practice devoted to leukemia, myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN). She will be developing clinical and translational research protocols and projects in the areas of leukemia, MDS and MPN.Dr. Desai is published in Cancer Epidemiology Biomarkers Prevention and International Journal of Molecular Epidemiology and Genetics. She is the lead author and co-author on numerous WHI (Women's Health Initiative) paper proposals and has presented abstracts at national meetings. She is a member of American Society of Hematology (ASH) and American Society of Clinical Oncology (ASCO) and has served on the ASCO University Committee.

Care Philosophy: After developing an interest in fighting cancer in medical school, I was fortunate to work with and learn from leadersin the field of genitourinary oncology during internship, residency, and fellowship training. I feel fortunate to have joined the faculty at Weill Cornell to work with renowned mentors and colleagues in both medical oncology and urology. Together I am confident we will make progress towards increasing the cure rate and decreasing suffering from these diseases.

Care Philosophy: My first priority is the patient sitting in front of me. I have a longstanding interest in cancer care and have been specifically focused on lymphoma since my father was diagnosed with Hodgkin lymphoma when I was a medical student. At Weill Cornell, our experienced team of lymphoma specialists works together to determine the most appropriate therapy for each individual patient. Our group has played a key role in the development of many new therapies approved for lymphoma in recent years. As a result, our patients have early access to new and promising lymphoma treatments. We are fortunate to have a strong team of physician assistants, nurses, medical technicians, pharmacists, and administrative staff. This environment enables me to provide my patients with the best possible level of care.

Care Philosophy: Dr. Shah and the Gastrointestinal Oncology group are committed to providing excellent and personalized care for you and your loved ones. We would welcome the opportunity to take part in your care, whether it involves primary management or for consultation in conjunction with your treating physicians. Ensuring you are receiving the best and most comprehensive treatment for your malignancy is our aim. Please feel free to contact us for an appointment, or have your physician contact us to discuss your care.

Care Philosophy: As an oncologist, I believe providing the best state of the art treatment available for our patients. Our team of cancer specialists will ensure you will receive the best possible care.

Biography: Dr. Howard Greenberg, MD is a Hematology Specialist who practices in Astoria, NY. He is 77 years old and has been practicing for 52 years. Dr. Howard Greenberg, MD is affiliated with Mount Sinai Queens and Mount Sinai Hospital.

Biography: Dr. Katy Burris is a board certified dermatologist in the Department of Dermatology of Columbia University Medical Center (CUMC) who sees patients in the Columbia Doctors Third Avenue office. Dr. Burris graduated from the University of North Carolina at Chapel Hill with a Bachelors of Science in Public Health with Honors. She then attended the SUNY Downstate School of Medicine where she was elected to the Alpha Omega Alpha medical honor society. Dr. Burris completed her internship at St-Luke's Roosevelt Hospital and completed her training in Dermatology SUNY Downstate Medical Center, where she was selected to serve as chief resident during her final year. Dr. Burris is a fellow of the American Academy of Dermatology. She has published numerous articles in the peer-reviewed literature and has authored several book chapters. She has been invited to give numerous presentations in the field of dermatology at various community hospitals and academic departments, as well as at the annual Academy of Dermatology meeting. Dr. Burris prides herself on providing superior care with utmost compassion and sensitivity for all patients, and has been recognized as intern of the year at St-Luke's Roosevelt in 2008, Kings County Dermatology resident of the year in 2011, and Kings County Dermatology attending physician of the Year in 2013. Dr. Burris is committed to volunteerism, both at home and abroad. She participates in numerous community based skin cancer screening events and volunteers with several local charities. She has also traveled to Kenya, El Salvador, and Honduras serving those in need.

Care Philosophy: One of the most gratifying aspects of practicing at Weill Cornell has been the close collaborations with talented clinicians and scientists in the diagnosis and management of complex blood disorders. In my new role, I look forward to providing the same personal care to my patients utilizing the latest diagnostic tools and therapeutic modalities to improve patient outcomes.

Care Philosophy: My practice focuses on treating gastrointestinal malignancies, including colorectal, pancreatic, stomach, biliary, neuroendocrine, and liver cancers. I place great value on having strong physician-patient relationships and feel this is especially important in cancer care. I not only provide state-of-the art cancer treatment for my patients and their families, but comprehensive support through a compassionate and multidisciplinary approach. Through clinical research, I am able to offer my patients access to the latest therapies such as radiolabeled monoclonal antibodies, cancer "vaccines," immunotherapy, and other novel targeted agents. At Weill Cornell Medicine and New York-Presbyterian Hospital, we utilize a bench to bedside approach and are committed to bringing the most promising new treatments out of the lab and directly to patients often years before they are widely available elsewhere